Every year, more than 12 million people suffer from strokes. With 6.5 million dead and many left with permanent disability, it is one of the leading causes of death and disability worldwide.

Today, we’ll learn about the stroke pathway and secondary stroke risk as well as the underlying diseases that are connected to stroke and how they can be identified and treated.

In this episode, host Wiebke Plenkers, product line head for ON THE SPOT, Siemens Healthineers global mobile CT solutions, is joined by Mira Katan, MD, head of Stroke Unit and deputy head of Acute Neurology at University Hospital Basel in Switzerland and Carlos Molina, MD, head of Neurology Section and director of Stroke Unit at Barcelona’s Vall d’Hebron Research Institute.

What You’ll Learn in This Episode:

• The pathway for an incoming patient after it is determined that they are suffering from a stroke
• Determining the type and severity of the stroke is an important deciding factor for successful treatment
• Modern imaging techniques support in the identification between an ischemic or hemorrhagic stroke
• Secondary stroke events are a significant risk for many stroke patients
• Educating patients is key in preventing secondary stroke events
• Implementation of telemedicine is just one of the advances that might improve outcomes for stroke patients in the future

Connect with Wiebke Plenkers

•LinkedIn

Connect with Mira Katan

•LinkedIn

Connect with Carlos Molina

•LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

In medical imaging, there is a constantly growing gap between the need for diagnostic imaging and the availability of specialist staff. At the same time, groundbreaking developments in the field of artificial intelligence continue to transform the face of the imaging field as we know it. In fact, AI is currently being used as an efficient and cost-reducing solution to a variety of industry challenges.

Today, you’ll hear several panel conversations discussing generative AI in radiology, recorded live at the European Congress of Radiology. Held this year in Vienna, the ECR is one of the leading events in radiology as well as one of the world’s largest international meetings of radiology professionals, radiographers, physicists, and industry representatives.

In this episode, host Fabian Schoeck, Head of Global Product Management for Artificial Intelligence Products at Siemens Healthineers, is joined by Dr. Johannes Haubold, Senior Physician for Clinical AI Integration at University Hospital Essen and Isabelle Ayx, a Senior Radiologist at University Medical Center Mannheim, all based in Germany.

What You’ll Learn in This Episode:

• The potential and the limitations of generative AI in radiology
• AI can be used to help with early detection
• Generative AI can transform clinical workflows
• How can AI can pave the way for more accurate and efficient diagnostics
• Artificial intelligence can process massive amounts of data, allowing for huge advantages to research
• What’s coming next in AI development for the radiology field

Connect with Fabian Schoeck

• LinkedIn

Connect with Johannes Haubold

• LinkedIn

Connect with Isabelle Ayx

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

Lung cancer has the highest mortality rate of all cancers. Globally, it is the deadliest cancer among men and women. One of the biggest contributing factors to lung cancer’s devastation is that it often goes undetected in its early stages. Because the lungs don’t have pain receptors and the chest cavity allows a relatively spacious growing environment for tumors, symptoms typically don’t manifest until the disease has progressed significantly. It’s for these reasons that screening higher-risk patients for lung cancer is so important, as early detection provides the best chance of survival from the disease.

In this episode, Dr. Victoria Schneider, clinical oncology consultant at Siemens Healthineers, is joined by Dr. Richard Booton, clinical director for lung cancer and thoracic surgery at Wythenshawe Hospital and professor of respiratory medicine at the University of Manchester in the UK; Rimma Kondrashova, a radiology resident at Hannover Medical School in Germany; and doctors David Yankelevitz and Claudia Henschke, both radiologists and professors of radiology at Mount Sinai’s Icahn School of Medicine in New York City.

You’ll hear from these experts about the importance of early detection, the programs that have been recently rolled out to increase survival rates, and some of the exciting new advancements in the field.

What You’ll Learn in This Episode:

      •    Early detection is a key factor in the successful treatment of lung cancer 

      •    Government funded screening programs in the US and the UK have made significant headway in early-stage lung cancer diagnoses 

      •   In Germany, the HANSE Study was created to assess what a successful national lung cancer screening program might look like for the country

      •    Mobile screening clinics have been implemented in order to move lung cancer screenings out of hospitals and into more readily accessible community spaces

• AI has had a major impact on several areas of lung cancer screenings, including improving the image resolution of scans and helping radiologists by minimizing the often-tedious work of reading images

Connect with Victoria Schneider

• LinkedIn

Connect with Richard Booton

• LinkedIn

Connect with David Yankelevitz

• LinkedIn

Connect with Claudia Henschke

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.